Abstract:Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counseling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.

Double gonosomal mosaicism as an unusual hereditary mechanism in familial GRIN2A -related disorder

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Living Birth Following Preimplantation Genetic Testing for Monogenic Disorders to Prevent Low-Level Germline Mosaicism Related Nicolaides–Baraitser Syndrome

Identification of of a PAX2 Mutation from Maternal Mosaicism Causes Recurrent Renal Disorder in Siblings

De novo GRIN2A variants associated with epilepsy and autism and literature review

Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent

GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects

Identification of Paternal Germline Mosaicism by MicroSeq and Targeted Next‐generation Sequencing

Mosaicism of a Missense SCN1A Mutation and Dravet Syndrome in a Roma/Gypsy Family

RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2A

Genomic Mosaicism in Paternal Sperm and Multiple Parental Tissues in a Dravet Syndrome Cohort

Gonadal Mosaicism for an ASH1L Intragenic Deletion Makes a Bridge Between MRD52 and 1q22 Microdeletion

Assessment of parental mosaicism rates in neurodevelopmental disorders caused by apparent de novo pathogenic variants using deep sequencing

Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort

Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene

GRIN2A Variants Associated with Idiopathic Generalized Epilepsies.

Low‐grade parental gonosomal mosaicism in CHD2 siblings with Smith–Magenis‐like syndrome

Novel compound heterozygous GPR56 gene mutation in a twin with lissencephaly: A case report